SA PRO
Free Account
10x Genomics, Inc.TXGNASDAQ
LOADING
|||
OverviewChartsNewsFundamentalsEarningsAnalysts

Analyst Sentiment

Analysts are neutral — opinion is divided on direction.

Consensus Rating
Hold
21 analysts·High coverage
43%
Rating Distribution
Strong Buy
00%
Buy
943%
Hold
1152%
Sell
15%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Current price is 8% above analyst consensus — modest downside expected.

Bear Case
$13.00
-35%
Consensus
$18.33
-8%
Bull Case
$22.00
+10%
Price Range21 analysts
Low
Consensus
High
$13.00
$22.00
Current Target
Current Price
$19.95
Above Target
$1.62

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Jan 12, 2026Needham
10X Genomics (TXG) PT Raised to $21 at BofA Securities
Target:$21.00
+2.6%from $20.46
Dec 22, 2025Canaccord Genuity
10x Genomics price target raised to $20 from $19 at Canaccord
Target:$20.00
+24.6%from $16.05
Dec 15, 2025Barclays
10x Genomics price target raised to $22 from $17 at Barclays
Target:$22.00
+42.4%from $15.45
Dec 1, 2025Morgan Stanley
10x Genomics assumed at Equal Weight from Overweight at Morgan Stanley
Target:$20.00
+10.6%from $18.08
Aug 11, 2025Canaccord Genuity
10x Genomics price target raised to $16 from $15 at Canaccord
Target:$16.00
+29.1%from $12.39
Aug 8, 2025UBS
10x Genomics price target raised to $13 from $12 at UBS
Target:$13.00
+8.1%from $12.03
Aug 8, 2025Deutsche Bank
10x Genomics price target raised to $14 from $10 at Deutsche Bank
Target:$14.00
+13.9%from $12.29
Aug 13, 2024Morgan Stanley
10x Genomics price target lowered to $46 from $50 at Morgan Stanley
Target:$46.00
+134.1%from $19.65
Jul 23, 2024Canaccord Genuity
10x Genomics price target lowered to $32 from $50 at Canaccord
Target:$32.00
+76.7%from $18.11
Jul 10, 2024Deutsche Bank
Deutsche downgrades 10x Genomics on demand erosion from competition
Target:$25.00
+37.0%from $18.25
Jun 28, 2024Barclays
10x Genomics price target lowered to $24 from $36 at Barclays
Target:$24.00
+20.9%from $19.85
Jun 3, 2024Jefferies
Jefferies Starts 10X Genomics (TXG) at Hold
Target:$24.00
+7.0%from $22.42
May 1, 2024Barclays
10x Genomics price target lowered to $36 from $45 at Barclays
Target:$36.00
+23.0%from $29.28
Apr 10, 2024Barclays
10x Genomics price target lowered to $45 from $55 at Barclays
Target:$45.00
+20.4%from $37.37
Dec 14, 2022Deutsche Bank
Deutsche Bank Initiates Coverage On 10x Genomics with Buy Rating, Announces Price Target of $50
Target:$50.00
+42.0%from $35.21

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance